Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain TXMD message board posts where the ticker symbol TXMD has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest TXMD SEC Filings

Filings Format Description Filing Date File/Film Number
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001387131-18-001945 (34 Act)  Size: 3 MB
2018-05-07 001-00100
18811728
8-K  Documents Current report, items 1.01, 2.02, 2.03, 7.01, and 9.01
Acc-no: 0001387131-18-001909 (34 Act)  Size: 169 KB
2018-05-03 001-00100
18803868
DEFA14A  Documents Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Acc-no: 0001387131-18-001817 (34 Act)  Size: 64 KB
2018-04-27 001-00100
18785369
DEF 14A  Documents Other definitive proxy statements
Acc-no: 0001387131-18-001815 (34 Act)  Size: 694 KB
2018-04-27 001-00100
18785343
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001387131-18-001647 Size: 5 KB
2018-04-18
SC 13D/A  Documents [Amend] General statement of acquisition of beneficial ownership
Acc-no: 0001387131-18-001600 (34 Act)  Size: 138 KB
2018-04-16 005-32384
18755333
8-K  Documents Current report, items 7.01 and 9.01
Acc-no: 0001387131-18-001522 (34 Act)  Size: 31 KB
2018-04-11 001-00100
18749090
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001387131-18-001440 Size: 3 KB
2018-04-05
8-K  Documents Current report, items 5.02, 7.01, and 9.01
Acc-no: 0001387131-18-001328 (34 Act)  Size: 59 KB
2018-04-02 001-00100
18727211
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001387131-18-001129 Size: 5 KB
2018-03-19
More TXMD SEC Filings


Related news from
Mon, 21 May 2018
12:43:12 +0000
Options Traders Expect Huge Moves in TherapeuticsMD (TXMD) Stock
Investors in TherapeuticsMD (TXMD) need to pay close attention to the stock based on moves in the options market lately.
Wed, 16 May 2018
20:30:00 +0000
TherapeuticsMD Announces Investor and Analyst Day on June 4
TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced that the Company will host an Investor and Analyst Day on Monday, June 4, 2018, in New York City. The event will feature presentations by the TherapeuticsMD senior leadership team and industry experts to provide an overview of the company’s outlook and strategy for its two late-stage women’s health product candidates: TX-004HR for treatment of moderate-to-severe vaginal pain associated with sexual activity (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause, and TX-001HR for treatment of moderate-to-severe vasomotor symptoms (VMS), due to menopause. The Prescription Drug User Fee Act (PDUFA) target action date for the completion of the U.S. Food and Drug Administration (FDA) review of the New Drug Application (NDA) for TX-004HR is May 29, 2018 and for TX-001HR is October 28, 2018.
Tue, 15 May 2018
21:52:31 +0000
Edited Transcript of TXMD earnings conference call or presentation 3-May-18 8:30pm GMT
Q1 2018 TherapeuticsMD Inc Earnings Call
Wed, 09 May 2018
12:07:38 +0000
See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
TherapeuticsMD Inc NASDAQ/NGS:TXMD
Thu, 03 May 2018
22:20:45 +0000
TherapeuticsMD: 1Q Earnings Snapshot
On a per-share basis, the Boca Raton, Florida-based company said it had a loss of 11 cents. The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...
Thu, 03 May 2018
20:05:00 +0000
TherapeuticsMD Announces First Quarter 2018 Financial Results
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced its financial results for the quarter ended March 31, 2018.
Tue, 01 May 2018
20:30:00 +0000
TherapeuticsMD to Host First Quarter Financial Results Conference Call and Webcast on May 3
TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced that it will host a conference call and live audio webcast to discuss its first quarter financial and business results on Thursday, May 3. TherapeuticsMD Chief Executive Officer Robert G. Finizio and Chief Financial Officer Dan Cartwright will host the call.
Wed, 11 Apr 2018
10:00:00 +0000
TherapeuticsMD Enters Into Label Negotiations for TX-004HR
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced that the Company has entered into negotiations with the U.S. Food and Drug Administration regarding the proposed label for TX-004HR, the Company’s investigational applicator-free estradiol vaginal softgel capsule for the treatment of moderate-to-severe vaginal pain during sexual intercourse , a symptom of vulvar and vaginal ...
Mon, 02 Apr 2018
11:00:00 +0000
TherapeuticsMD Announces Expansion of Board of Directors
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced the appointment of Jane F. Barlow, M.D., M.B.A., M.P.H. as an independent director to the Board of Directors.
Mon, 19 Mar 2018
12:10:00 +0000
TherapeuticsMD, New PipelineNDA Development, Analysts Target and PDUFA Date
NEW YORK, NY / ACCESSWIRE / March 19, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
Fri, 09 Mar 2018
13:10:00 +0000
Today’s Research Reports on Stocks to Watch: AcelRx Pharmaceuticals and TherapeuticsMD
NEW YORK, NY / ACCESSWIRE / March 9, 2018 / Biotech stocks AcelRx and TherapeuticsMD both saw gains on Thursday with the gains extended into after-hours trading. AcelRx moved higher despite reporting a ...
Thu, 08 Mar 2018
21:15:00 +0000
TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced the acceptance of the NDA for TX-001HR by the U.S. Food and Drug Administration .
Tue, 06 Mar 2018
21:30:00 +0000
TherapeuticsMD to Present at Two Upcoming Investor Conferences
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced that the Company will participate in the Cowen and Company 38th Annual Healthcare Conference on March 12, and the Oppenheimer 28th Annual Healthcare Conference on March 20.
Fri, 23 Feb 2018
22:49:42 +0000
TherapeuticsMD Inc (TXMD) Files 10-K for the Fiscal Year Ended on December 31, 2017
TherapeuticsMD Inc (NASDAQ:TXMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
Fri, 23 Feb 2018
12:20:00 +0000
Wired News - Merck to Acquire Australia-based Viralytics to Broaden Immuno-Oncology Portfolio
Stock Monitor: TherapeuticsMD Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 23, 2018 / Active-Investors.com has just released a free research report on Merck & Co. (NYSE: MRK ). If you want ...
Wed, 21 Feb 2018
15:01:03 +0000
Edited Transcript of TXMD earnings conference call or presentation 20-Feb-18 9:30pm GMT
Q4 2017 TherapeuticsMD Inc Earnings Call
Tue, 20 Feb 2018
22:29:25 +0000
TherapeuticsMD reports 4Q loss
On a per-share basis, the Boca Raton, Florida-based company said it had a loss of 10 cents. The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ...
Tue, 20 Feb 2018
21:05:00 +0000
TherapeuticsMD Announces Fourth Quarter and Full Year 2017 Financial Results
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced its fourth quarter and full-year financial results for 2017.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is a great group of value seeking investors, who are most generous in sharing their research, news, business expertise, and investment experience. It is an invaluable resource, and brings many 'lessons learned' to the group." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards